Big blocks sell well as Aspen, ISS top $1.9bn
Two block trades of around $1bn went well on Thursday night, as GlaxoSmithKline sold half its remaining 12.4% stake in Johannesburg-listed Aspen Pharmacare, while private equity funds shed the last chunk of ISS, the Danish cleaning firm.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: